a compliance officer for a start-up biologic company that is planning to launch its first clinical trial. Your colleagues have asked you for your input on drafting and negotiating the clinical trial agreement. They are particularly interested in the sections concerning confidentiality, indemnification, data ownership, intellectual property, and publication. The compliance officer to review language for these sections from model agreements available online and, drawing from these models, draft a memo that (1) presents at least two different options for each of the sections, and (2) explains the implications of choosing one of the options over the other.